Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to recipients’ variants-Reference-Cited by-同舟云学术

Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to recipients’ variants

Published:2024-03-21 Issue:6 Volume:56 Page:423-433
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Khawaja T.¹²³⁴,Kajova M.¹²³⁴,Levonen I.¹³,Pietilä J. P.¹³⁴,Välimaa H.¹⁵,Paajanen J.¹⁶,Pakkanen S. H.¹³⁴,Patjas A.¹³⁴,Montonen R.⁵,Miettinen S.⁵⁷,Virtanen J.⁵⁷,Smura T.⁵,Sironen T.⁵⁷,Fagerlund R.⁵,Ugurlu H.⁵,Iheozor-Ejiofor R.⁵⁷,Saksela K.⁵⁸,Vahlberg T.⁹,Ranki A.¹⁰,Vierikko A.¹¹,Ihalainen J.¹¹,Vapalahti O.⁵⁷⁸,Kantele A.¹²³⁴

Affiliation:

1. Meilahti Vaccine Research Center, MeVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

2. Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

3. Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland

4. FIMAR, Multidisciplinary Center of Excellence in Antimicrobial Resistance Research, University of Helsinki, Helsinki, Finland

5. Department of Virology, University of Helsinki, Helsinki, Finland

6. Department of Pulmonary Medicine, Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

7. Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland

8. HUS Diagnostic Centre, HUSLAB, Clinical Microbiology, Helsinki University Hospital, Helsinki, Finland

9. Department of Biostatistics, University of Turku and Turku University Hospital, Turku, Finland

10. Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

11. Finnish Red Cross Blood Service, Helsinki, Finland

Funder

Finnish Government Subsidy for Health Science Research

Finnish Medical Foundationand the Academy of Finland

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2024.2329957

Reference46 articles.

1. Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?

2. The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

3. Directorate-General for Health and Food Safety An EU programme of COVID-19 convalescent plasma collection and transfusion: guidance on collection testing processing storage distribution and monitored use. Brussels: european Comission; 2021.

4. Safety Update

5. Safety of COVID‐19 convalescent plasma: A definitive systematic review and meta‐analysis of randomized controlled trials

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients;Life;2024-06-22

2. Correction;Infectious Diseases;2024-03-31

3. Towards the identification of the correct place for convalescent plasma among COVID-19 therapies;Infectious Diseases;2024-03-29